Merion, Inc. (EWLU) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
EWLU steht fuer Merion, Inc., ein Consumer Defensive-Unternehmen mit einem Kurs von $ (Marktkapitalisierung 0). Die Aktie erzielt 63/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.
Zuletzt analysiert: 16. März 2026Merion, Inc. (EWLU) Konsumgueeter-Geschaeftsueberblick
Merion, Inc. focuses on health and nutritional supplements, offering products like Noir Naturel and Viwooba. Operating in the consumer defensive sector, the company targets the People's Republic of China and the United States, selling through its website and wholesale distributors. With a small team, Merion faces challenges in a competitive market.
Investmentthese
Merion, Inc. presents a high-risk, high-reward investment profile. The company's negative profit margin of -80.8% and a market capitalization of $0.00B indicate significant financial challenges. Growth catalysts include potential expansion of its online sales channels and increased penetration into the Chinese market. However, the company's small size, limited resources, and OTC Other listing pose substantial risks. The negative beta of -34.99 suggests an inverse correlation with the market, which may offer some downside protection during market downturns. Investors should carefully consider the company's financial instability and competitive disadvantages before investing.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.00B, indicating a micro-cap status with limited liquidity.
- Negative P/E ratio of -0.01, reflecting the company's current unprofitability.
- Gross margin of 30.1%, suggesting some ability to control production costs despite overall losses.
- Profit margin of -80.8%, highlighting significant operational inefficiencies and high expenses.
- Beta of -34.99, indicating a strong inverse correlation with the market, potentially offering downside protection.
Wettbewerber & Vergleichsunternehmen
Staerken
- Niche product offerings in health and nutritional supplements.
- Direct-to-consumer sales channel.
- Established presence in the Chinese market.
- Proprietary formulations for some products.
Schwaechen
- Small market capitalization and limited financial resources.
- Negative profit margin and overall unprofitability.
- High reliance on a small number of products.
- Limited brand recognition compared to larger competitors.
Katalysatoren
- Upcoming: Potential expansion of online sales channels through platforms like Amazon and Alibaba by Q4 2026.
- Ongoing: Continuous investment in research and development for new product innovation.
- Ongoing: Strategic partnerships with local distributors in the Chinese market to increase market penetration.
Risiken
- Ongoing: Intense competition from larger, more established companies in the health and nutritional supplement market.
- Potential: Changes in regulations and consumer preferences impacting product demand.
- Potential: Economic downturns leading to reduced consumer spending on discretionary items.
- Ongoing: Supply chain disruptions and increased raw material costs affecting profitability.
- Potential: Limited financial resources hindering growth and expansion efforts.
Wachstumschancen
- Expansion of Online Sales Channels: Merion can increase its revenue by expanding its online presence through platforms like Amazon, Alibaba, and other e-commerce marketplaces. The global e-commerce market is expected to reach $6.2 trillion in 2024. By leveraging these platforms, Merion can reach a wider audience and increase sales. This expansion could be implemented within the next year, providing a near-term growth opportunity.
- Increased Penetration into the Chinese Market: The Chinese market represents a significant growth opportunity for Merion, given the increasing demand for health and nutritional supplements. The Chinese dietary supplements market is projected to reach $45 billion by 2025. By tailoring its products to meet the specific needs of Chinese consumers and establishing strategic partnerships with local distributors, Merion can increase its market share. This initiative could be implemented over the next two to three years.
- Product Innovation and Development: Merion can drive growth by investing in research and development to create new and innovative products that meet evolving consumer needs. The global market for anti-aging products is expected to reach $421.4 billion by 2030. By developing new products in this area, Merion can attract new customers and increase its revenue. This is an ongoing opportunity that requires continuous investment and innovation.
- Strategic Partnerships and Acquisitions: Merion can accelerate its growth by forming strategic partnerships with other companies in the health and wellness sector or by acquiring smaller companies with complementary products or technologies. This can provide access to new markets, distribution channels, and product lines. Identifying and executing such partnerships or acquisitions could take one to two years.
- Enhanced Marketing and Branding Efforts: Merion can improve its brand awareness and attract more customers by investing in targeted marketing and branding campaigns. This includes online advertising, social media marketing, and public relations. Effective marketing can increase brand recognition and drive sales. This is an ongoing opportunity that requires continuous investment and adaptation to changing consumer preferences.
Chancen
- Expansion into new markets and distribution channels.
- Development of new and innovative products.
- Strategic partnerships and acquisitions.
- Increased demand for health and nutritional supplements.
Risiken
- Intense competition from larger, more established companies.
- Changes in regulations and consumer preferences.
- Economic downturns and reduced consumer spending.
- Supply chain disruptions and increased raw material costs.
Wettbewerbsvorteile
- Proprietary formulations for some of its supplements.
- Established distribution network in China and the United States.
- Brand recognition in specific niche markets.
- Direct-to-consumer sales channel through its website.
Ueber EWLU
Merion, Inc., established in 2007 and headquartered in West Covina, California, formulates, markets, and distributes health, nutritional supplements, and personal care products. Originally named E-World USA Holding, Inc., the company rebranded to Merion, Inc. in June 2017. Its product portfolio includes Noir Naturel, a hair color product; Viwooba (1-3), a natural aphrodisiac supplement for men; Lady-S, a weight loss supplement for women; Gold King, a nutritional supplement for antioxidant support and liver health; New Power, a supplement supporting heart health; Taibao, a supplement enhancing physical performance and energy metabolism; and ReMage Power, an anti-aging supplement. Merion distributes its products directly to consumers through its online platform, merionus.com, and to wholesale distributors via phone and electronic communication. The company's primary markets are the People's Republic of China and the United States. With a small team of six employees, Merion faces significant competition from larger, more established players in the health and wellness sector.
Was das Unternehmen tut
- Develops and markets health and nutritional supplements.
- Offers personal care products.
- Sells products directly to consumers through its website, merionus.com.
- Distributes products to wholesale distributors.
- Focuses on the People's Republic of China and the United States markets.
- Provides products such as hair color, aphrodisiac supplements, and weight loss supplements.
Geschaeftsmodell
- Direct-to-consumer sales through merionus.com.
- Wholesale distribution to retailers.
- Revenue generation through product sales in the health and nutritional supplement market.
- Focus on specific product categories like anti-aging, heart health, and weight loss.
Branchenkontext
Merion, Inc. operates within the competitive consumer defensive sector, specifically in the packaged foods and nutritional supplements market. This sector is characterized by stable demand, even during economic downturns. The global dietary supplements market is projected to reach $230.73 billion by 2027, growing at a CAGR of 8.6%. Merion faces competition from larger, more established companies with greater resources and brand recognition. The company's success depends on its ability to differentiate its products, effectively market to its target audience, and navigate the complex regulatory landscape in both the United States and China.
Wichtige Kunden
- Individual consumers seeking health and nutritional supplements.
- Wholesale distributors in the health and wellness sector.
- Customers in the People's Republic of China and the United States.
- Consumers looking for specific health benefits such as anti-aging, heart health, and weight loss.
Finanzdaten
Chart & Info
Merion, Inc. (EWLU) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer EWLU verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer EWLU.
Kursziele
Wall-Street-Kurszielanalyse fuer EWLU.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von EWLU auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Ding Hua Wang
CEO
Ding Hua Wang serves as the CEO of Merion, Inc., overseeing the company's operations and strategic direction. Information on Mr. Wang's detailed career history and educational background is not available. As CEO, he is responsible for managing the company's product development, marketing, and distribution efforts in the health and nutritional supplement market. He also manages a small team of six employees.
Erfolgsbilanz: Due to limited available information, it is difficult to assess Ding Hua Wang's specific achievements and strategic decisions at Merion, Inc. The company's financial performance, as indicated by its negative profit margin and small market capitalization, suggests significant challenges during his tenure. Further information is needed to evaluate his overall track record.
EWLU OTC-Marktinformationen
The OTC Other tier, also known as the Pink Sheets, represents the lowest tier of over-the-counter (OTC) markets. Companies listed on this tier often have limited or no reporting requirements, making it difficult for investors to obtain reliable information. These companies may be distressed, have limited operations, or be unwilling to meet the listing requirements of higher-tier OTC markets like OTCQB or OTCQX, or exchanges like NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the lack of transparency and regulatory oversight.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited or no financial reporting requirements, making it difficult to assess the company's financial health.
- Low trading volume and wide bid-ask spreads, leading to potential illiquidity and price volatility.
- Higher risk of fraud and manipulation due to lack of regulatory oversight.
- Potential for delisting or suspension of trading.
- Limited access to capital and funding opportunities.
- Verify the company's legal status and registration.
- Attempt to obtain and review any available financial statements, even if unaudited.
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Understand the company's revenue sources and customer base.
- Check for any legal or regulatory issues.
- Consult with a financial advisor before investing.
- Company has a functional website and contact information.
- The company has been in operation for several years.
- The company has a registered address and physical presence.
- The company's products are available for purchase.
- The company responds to inquiries from investors and customers.
Merion, Inc. Aktie: Wichtige Fragen beantwortet
What are the key factors to evaluate for EWLU?
Merion, Inc. (EWLU) currently holds an AI score of 63/100, indicating moderate score. Key strength: Niche product offerings in health and nutritional supplements.. Primary risk to monitor: Ongoing: Intense competition from larger, more established companies in the health and nutritional supplement market.. This is not financial advice.
How frequently does EWLU data refresh on this page?
EWLU prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven EWLU's recent stock price performance?
Recent price movement in Merion, Inc. (EWLU) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Niche product offerings in health and nutritional supplements.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider EWLU overvalued or undervalued right now?
Determining whether Merion, Inc. (EWLU) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying EWLU?
Before investing in Merion, Inc. (EWLU), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding EWLU to a portfolio?
Potential reasons to consider Merion, Inc. (EWLU) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Niche product offerings in health and nutritional supplements.. Additionally: Direct-to-consumer sales channel.. The AI-driven MoonshotScore of 63/100 reflects solid quantitative fundamentals. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of EWLU?
Yes, most major brokerages offer fractional shares of Merion, Inc. (EWLU) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track EWLU's earnings and financial reports?
Merion, Inc. (EWLU) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for EWLU earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Financial data is based on the most recently available information.
- OTC market data may be limited or unreliable.
- AI analysis is pending and may provide further insights.